ADA2 and systemic lupus erythematosus: Studies have found a dramatic increase in ADA2 activity in immune diseases such as systemic lupus erythematosus and tuberculosis, while ADA2 levels in pleural effusions have also been used as a marker for tuberculosis (47, 48).